Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | dopamine receptor D2 | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | thymidylate synthase | 0.1411 | 0.1774 | 0.1276 |
Schistosoma mansoni | dihydrofolate reductase | 0.7173 | 1 | 1 |
Brugia malayi | Dihydrofolate reductase | 0.7173 | 1 | 1 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.7173 | 1 | 1 |
Loa Loa (eye worm) | thymidylate synthase | 0.1411 | 0.1774 | 0.1774 |
Echinococcus multilocularis | dihydrofolate reductase | 0.7173 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0682 | 0.0735 | 0.0735 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.1411 | 0.1774 | 0.1137 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.4509 | 0.6196 | 1 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.4509 | 0.6196 | 0.5 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.7173 | 1 | 1 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.4509 | 0.6196 | 0.5 |
Echinococcus granulosus | dihydrofolate reductase | 0.7173 | 1 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.4509 | 0.6196 | 0.5 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.7173 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0671 | 0.0719 | 0.5 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.4509 | 0.6196 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0682 | 0.0735 | 0.0735 |
Onchocerca volvulus | 0.1411 | 0.1774 | 0.5 | |
Chlamydia trachomatis | dihydrofolate reductase | 0.7173 | 1 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.4509 | 0.6196 | 0.5 |
Echinococcus granulosus | thymidylate synthase | 0.1411 | 0.1774 | 0.1276 |
Brugia malayi | hypothetical protein | 0.0671 | 0.0719 | 0.0719 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.7173 | 1 | 1 |
Brugia malayi | thymidylate synthase | 0.1411 | 0.1774 | 0.1774 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | nM | The binding affinity of the compound was determined by measuring its ability to displace [3H]-spiperone radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D3; ND=not determined | ChEMBL. | 9513604 |
Ki (binding) | 0 nM | The binding affinity of the compound was determined by measuring its ability to displace [3H]-spiperone radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D3; ND=not determined | ChEMBL. | 9513604 |
Ki (binding) | = 10 nM | The binding affinity of the compound was determined by measuring its ability to displace [3H]-8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation | ChEMBL. | 9513604 |
Ki (binding) | = 10 nM | The binding affinity of the compound was determined by measuring its ability to displace [3H]-8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation | ChEMBL. | 9513604 |
Ki (binding) | = 46 nM | Binding affinity determined by measuring its ability to displace [3H]-N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2 | ChEMBL. | 9513604 |
Ki (binding) | = 46 nM | Binding affinity determined by measuring its ability to displace [3H]-N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2 | ChEMBL. | 9513604 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.